tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ASLN Stock Latest News

ASLAN Pharmaceuticals trading halted, news pending
The FlyASLAN Pharmaceuticals trading halted, news pending
3d ago
ASLN
ASLAN Pharmaceuticals Adjusts ADS Ratio
PremiumCompany Announcements
ASLAN Pharmaceuticals Adjusts ADS Ratio
21d ago
6K
ASLN
ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
PremiumPress Releases
ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
21d ago
ASLN
Aslan Pharmaceuticals plans to implement ADS ratio change
PremiumThe Fly
Aslan Pharmaceuticals plans to implement ADS ratio change
21d ago
ASLN
Aslan Pharmaceuticals files to sell 61.9M ordinary shares for holders
PremiumThe Fly
Aslan Pharmaceuticals files to sell 61.9M ordinary shares for holders
23d ago
ASLN
Aslan Pharmaceuticals Amends Loan Conversion Terms
PremiumCompany AnnouncementsAslan Pharmaceuticals Amends Loan Conversion Terms
1M ago
6K
ASLN
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
PremiumPress Releases
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
2M ago
ASLN
Aslan Pharmaceuticals presents data on eblasakimab as ATS conference
PremiumThe Fly
Aslan Pharmaceuticals presents data on eblasakimab as ATS conference
2M ago
ASLN
ASLAN Pharmaceuticals Excels in Eblasakimab Trials
PremiumCompany Announcements
ASLAN Pharmaceuticals Excels in Eblasakimab Trials
2M ago
6K
ASLN
Aslan Pharmaceuticals reports Q1 EPS (53c) vs. ($1.29) last year
PremiumThe Fly
Aslan Pharmaceuticals reports Q1 EPS (53c) vs. ($1.29) last year
2M ago
ASLN
Eblasakimab Shows Promise for AD Patients
PremiumCompany Announcements
Eblasakimab Shows Promise for AD Patients
2M ago
6K
ASLN
Aslan to present additional data from TREK-DX study during KOL event
PremiumThe Fly
Aslan to present additional data from TREK-DX study during KOL event
2M ago
ASLN
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
PremiumPress ReleasesASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
2M ago
ASLN
Aslan Pharmaceuticals announces expansion of collab with Zenyaku
PremiumThe Fly
Aslan Pharmaceuticals announces expansion of collab with Zenyaku
2M ago
ASLN
ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
PremiumPress Releases
ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
2M ago
ASLN
Aslan Pharmaceuticals to host KOL panel discussion on Dupilumab
PremiumThe Fly
Aslan Pharmaceuticals to host KOL panel discussion on Dupilumab
2M ago
ASLN
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab
PremiumPress Releases
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab
2M ago
ASLN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ASLN
CDTX
Aslan Pharmaceuticals’ Eblasakimab Shows Promise
PremiumCompany Announcements
Aslan Pharmaceuticals’ Eblasakimab Shows Promise
2M ago
6K
ASLN
Aslan announces interim results from Phase 2 study of eblasakimab
PremiumThe FlyAslan announces interim results from Phase 2 study of eblasakimab
2M ago
ASLN
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
PremiumPress Releases
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
2M ago
ASLN
ASLAN Pharma Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
ASLAN Pharma Faces Nasdaq Compliance Challenge
3M ago
6K
ASLN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >